Daniel M. Schmitt
President, CEO and Director at Actuate Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Actuate Therapeutics Inc., 2 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 28, 2026 | Actuate Therapeutics Inc. | Open-market purchase | +140,844 | $0.36 | $50,000 |
| Aug 14, 2026 | Actuate Therapeutics Inc. | Option exercise | +272,056 | — | — |
| Aug 14, 2026 | Actuate Therapeutics Inc. | Shares withheld for tax | −120,521 | $1.01 | $121,726 |
| Feb 13, 2026 | Actuate Therapeutics Inc. | Option exercise | +272,055 | — | — |
| Feb 13, 2026 | Actuate Therapeutics Inc. | Shares withheld for tax | −121,874 | $4.33 | $527,714 |
Questions about Daniel M. Schmitt
What boards is Daniel M. Schmitt on?
Daniel M. Schmitt sits on the board of Actuate Therapeutics Inc.
What company is Daniel M. Schmitt the CEO of?
Daniel M. Schmitt has been President, CEO and Director of Actuate Therapeutics Inc. since August 2024.
How long has Daniel M. Schmitt served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.